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Abstract
Background Outcome and morbidity of redo antireflux surgery are suggested to be less satisfactory than those of primary
surgery. Studies reporting on redo surgery, however, are usually much smaller than those of primary surgery. The aim of this
study was to summarize the currently available literature on redo antireflux surgery.
Material and Methods A structured literature search was performed in the electronic databases of MEDLINE, EMBASE,
and Cochrane Central Register of Controlled Trials.
Results A total of 81 studies met the inclusion criteria. The study design was prospective in 29, retrospective in 15, and not
reported in 37 studies. In these studies, 4,584 reoperations in 4,509 patients are reported. Recurrent reflux and dysphagia
were the most frequent indications; intraoperative complications occurred in 21.4% and postoperative complications in
15.6%, with an overall mortality rate of 0.9%. The conversion rate in laparoscopic surgery was 8.7%. Mean(±SEM)
duration of surgery was 177.4±10.3 min and mean hospital stay was 5.5±0.5 days. Symptomatic outcome was successful in
81.1% and was equal in the laparoscopic and conventional approach. Objective outcome was obtained in 24 studies (29.6%)
and success was reported in 78.3%, with a slightly higher success rate in case of laparoscopy than with open surgery (85.8%
vs. 78.0%).
Conclusion This systematic review on redo antireflux surgery has confirmed that morbidity and mortality after redo surgery
is higher than after primary surgery and symptomatic and objective outcome are less satisfactory. Data on objective results
were scarce and consistency with regard to reporting outcome is necessary.
Keywords Gastro esophageal reflux disease . Antireflux
surgery . Nissen fundoplication . Dysphagia . Reoperation
Introduction
Antireflux surgery for refractory gastroesophageal reflux
disease (GERD) has satisfactory outcome in 85–90% of
patients.1–6 In the remaining 10–15%, reflux symptoms
persist, recur, or complications occur. Dysphagia is a
frequent complication of fundoplication.7 The indications
for reoperation are far from straightforward, varying from
severe recurrent symptoms with a more than adequate
anatomical result to recurrent abnormal anatomy without
any symptoms at all. Studies on reoperations also show
similar wide variations with a full range of abnormal
anatomy, symptoms and objective failure documented by
esophageal manometry, and pH monitoring.
In our recently published study on redo antireflux
surgery, morbidity and mortality were higher than after
primary antireflux surgery, with a symptomatic and objec-
tive success rate of 70% which is obviously inferior to the
outcome of primary surgery.4,8 Several other studies have
been published describing causes of failure of conventional
and laparoscopic antireflux surgery. Most studies have
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included only a small group of patients, so an adequate
impression on the outcome of reoperation is hard to extract
from such studies.
This study aims to summarize the currently available
literature on surgical reintervention after primary antire-
flux surgery focusing on morbidity, mortality, and
outcome in order to get a more complete overview of
the results of redo antireflux surgery and to give
guidelines about how patients should be informed on
their chances of success.
Material and Methods
Search Strategy
A literature search was performed in three electronic
databases, MEDLINE using the Pubmed search engine,
EMBASE, and the Cochrane Central Register of Controlled
Trials. The databases were searched for all years, up to
November 2008. Search terms were entered to identify the
relevant studies. Separate search terms were entered for the
intervention, i.e., surgical reintervention, and the disease,
i.e., GERD. For the disease, dysphagia was also used
because this is a frequent indication for reoperation. For
both the intervention and the disease, headwords in the
thesaurus of the three databases [Medical Subject Heading
(MeSH) Thesaurus in Pubmed and the Cochrane library and
the Emtree Thesaurus in EMBASE] and free text words in
title and abstract were used as search terms. The headwords
from the thesaurus and the different synonyms for free text
words were coupled by the Boolean operator “OR”. The
combination of search terms for the intervention and
disease were subsequently coupled by the Boolean operator
“AND”. The free text words and headwords identified in
the thesauruses are listed in Table 1.
Selection of Studies
The studies identified by the search strategy were indepen-
dently selected by two reviewers (E.F. and W.D.) based on
title, abstract, and full text. The literature was searched for
randomized controlled trials, cohort studies, and case–
control studies on the feasibility and/or outcome of surgical
reinterventions. Studies in children, on other indications for
primary surgery than GERD, conservative treatment of
symptoms following primary antireflux surgery, surgical
reintervention within 30 days after primary surgery, and
patients cohorts with less than ten patients were not
included. Only articles in English were included. Addition-
Intervention Disease
Free text words in title and abstract of MEDLINE, EMBASE, and the Cochrane Library
Refundoplication(s) Gastro esophageal reflux
Redo Gastro esophageal reflux disease(s)
Redo surgery Gastro esophageal reflux disorder(s)
Redo surgical procedure Gastro oesophageal reflux
Redo Nissen (fundoplication) Gastro oesophageal reflux disease(s)
Redo antireflux procedure Gastro oesophageal reflux disorder(s)
Redo antireflux surgery Gastroesophageal reflux
Reoperative antireflux surgery Gastroesophageal reflux disease(s)
Revisional surgery Gastroesophageal reflux disorder(s)
Reoperation(s) GERD
Reintervention(s) GORD
Surgical revision(s) Reflux disease(s)
Second look surgery Esophagitis
Oesophagitis
Dysphagia
Headwords in the Medical Subject Head (MeSH) Thesaurus of Pubmed and the Cochrane library
Reoperation Deglutition disorders
Second-look surgery Esophagitis
Headwords in the Emtree Thesaurus of EMBASE
Reoperation Stomach function disorder
Second look surgery Dysphagia
Esophagitis
Table 1 Search Terms used in
this Review
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ally, references of all selected publications were reviewed
for other relevant studies. In case of a difference in opinion
between the two reviewers about in- or exclusion of a
study, the opinion of a third reviewer was decisive.
Analysis of Data from Selected Studies
Data of the selected studies were independently acquired by
two reviewers (E.F. and W.D.). Study design, time period,
number of patients, sex ratio, and mean age were retrieved
from the studies. Based on the study design, each study was
qualified by a level of evidence according to the Oxford
Centre for Evidence Based Medicine Levels of Evidence.9
Type and approach of primary antireflux interventions and
reoperations, mean period between both interventions,
causes of failure of primary surgery and perioperative
information, i.e. intra- and postoperative complications,
mortality, number and causes of conversions in case of
laparoscopic reoperations, mean intraoperative blood loss,
duration of reoperations, and hospital stay were also
extracted from the included studies. Completeness of
follow-up, number of patients available, mean duration of
follow-up, method of obtaining outcome at follow-up, and
the definition and percentage of patients with successful
symptomatic and objective outcome were extracted from all
studies.
Data Analysis
Data were analysed using SPSS version 15.0 for Windows
(SPSS Inc., Chicago, IL, USA). Values were expressed as
mean±SEM. Statistical analysis was not performed owing




One thousand six hundred twenty-five articles were
eligible for further selection after removing duplicate
hits, and finally, 73 articles met the inclusion criteria
(Fig. 1). The references of these articles yielded eight more
articles for inclusion. These articles had not been identified
with the initial search strategy because of absence of
abstracts in the databases or atypical description for the
intervention or disease. Eventually, 81 articles were eligible
for inclusion in this study. According to the Oxford Centre
for Evidence Based Medicine Levels of Evidence, 27
studies had a level of evidence IIb (33.3%)8, 10–35, two
level of evidence IIIb (2.5%)36, 37, and 15 level of evidence
IV (18.5%)38–52. The remaining 37 studies (45.7%) were
cohort studies, but a level of evidence could not be
adjudged owing to unknown study design53–89. Baseline
characteristics extracted from the individual studies are
shown in Table 2.
Primary Antireflux Procedures
Total fundoplication performed by laparoscopy, laparotomy,
or thoracotomy was the most frequently reported primary
antireflux procedure followed by partial fundoplication
(Table 3). The type of primary antireflux procedure was
not reported in almost one third, and 241 patients (5.3%)
underwent more than one previous operation before
inclusion in the original studies.
Causes of Failure of Primary Antireflux Surgery
Causes of failure of the previous antireflux procedure were
reported on 3,175 reoperations in total. Intrathoracic wrap
migration, total or partial disruption of the wrap, and
telescoping were the most common anatomical abnormal-
ities encountered (Table 4). Esophageal motility disorder or
erroneous diagnosis, i.e., another primary disease than
GERD, were the causes of failure of the previous operation
in 62 patients (2.0%). In 194 reoperations (6.1%), no cause
of failure could be identified.
From six studies, it was shown that wrap disruption and
telescoping were more frequent after conventional primary
surgery, whereas disruption of hiatal repair and a tight wrap
were more frequent after laparoscopic primary repair
(Table 5).18,49,61,67,84,85 Intrathoracic wrap migration was
reported by Serafina et al.85 to be more frequent after
conventional primary procedures (13/17, 76.5% vs. 5/11,
45.5%), whereas Heniford et al.67 showed that this was
more frequent after laparoscopic primary repair (16/22,
72.7% vs. 13/33, 39.4%). In the study by Salminen et al.,84
intrathoracic wrap migration was equal after conventional
and laparoscopic primary surgery.
In five other studies,8,11,12,31,72 it was shown that
intrathoracic wrap migration and wrap disruption were
more frequent in the case of recurrent reflux, whereas in the
case of dysphagia, no cause of failure could be demon-
strated more frequently (Table 5).
Indications for Reoperations
Recurrent reflux and dysphagia were the most frequent
indications for reoperations (Table 3). In 1,435 reoperations
(31.3%), the indication for reoperation was not reported.
Preoperative symptoms were assessed by questionnaire in
26 studies (32.1%).10,14,17,18,23–25,28,30,33,36,45,53,54,56,61–
66,71,74,76,87,88 In most studies (93.8%), preoperative work-
up consisted of esophagogastroduodenoscopy, barium
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Number of patients (n) 4,509
Male 1,524 (33.8%)
Female 1,762 (39.1%)
Sex not reported 1,223 (27.1%)
Age (years) 51.3±0.8
Number of reoperations (n) 4,584
Study period (months) 10.8±0.7
Duration between primary surgery and reoperation (months) 38.3±4.1
Study design of the individual studies
Prospective cohort study 27 (33.3%)
Retrospective cohort study 14 (17.3%)
Prospective case–control study 2 (2.5%)
Retrospective case–control study 1 (1.2%)
Not reported 37 (45.7%)
Table 2 Baseline Characteris-
tics Extracted from the Included
Studies
Values are given as mean±SEM
unless otherwise stated
 
Cochrane Library (until 2008-11-26)*: 
 
- Intervention:  1 719 
- Disease:  2 758 
 
Total  0 042 
1 625 studies eligible for selection 
73 studies included
Selection based on subsequently title, abstract and 
full-text: 
 
- Inclusion criteria: 
   -  study design: RCT, cohort or case-control study 
   -  population: previous antireflux surgery 
   -  intervention: surgical reintervention 
   -  outcome: feasibility and/ or outcome after 
surgical reintervention 
 
- Exclusion criteria: 
- non-English studies 
- study population: 
   -  children 
   -  previous surgery not performed for GERD 
   -  < 10 patients 
- intervention: 
   -  primary antireflux surgery 
   -  conservative treatment 
   -  surgical reintervention within 30 days 
 after primary antireflux surgery 
[Search terms for “Intervention” coupled by the Boolean operator “OR”]  
AND  
[Search terms for “Disease” coupled by the Boolean operator “OR”] 
Medline (until 2008-11-26): 
 
- Intervention:  61 127 
- Disease:  47 482 
 
Total  01 032 
Embase (until 2008-11-26) †: 
 
- Intervention:  030 639 
- Disease:  167 156 
 
Total  001 059 
81 studies available for inclusion 
Reviewing references of selected articles 
* The Cochrane Central Register of Controlled Trials 
† Embase only 
Abbreviations: RCT, randomised controlled trial; GERD, gastroesophageal reflux disease 
Figure 1 Results of Search
Strategy and Selection of
Studies.
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swallow, and/or esophageal pH monitoring.10–28,30–41,43–
46,48–76,78,79,81–89
Type and Route of Reoperations
Total or partial fundoplication was the most frequently
performed reoperation (Table 3), whereas the type of
reoperation was not reported in 124 patients (2.7%). The
laparoscopic approach was used in 1,666 reoperations
(36.3%); 1,589 reoperations (34.7%) were performed by
the conventional (open) abdominal route and 1,041 (22.7%)
by thoracotomy. The approach of reoperation was not
reported in the remaining 288 reoperations (6.3%). More
than one reintervention was performed in 75 patients (1.7%).
The esophagus was totally or partially resected during
125 reoperations (2.7%). The reasons to perform esopha-
geal resection were severe esophagitis with or without
Barrett metaplasia,15,25,59 peptic stricture of the esopha-
gus,10,33,51,57,72,81 severely disturbed esophageal motili-
ty,26,44,57,81 or short esophagus.70,82 In 202 reoperations
(4.4%), gastric resection was performed. Indications for this
were alkaline reflux,10 dense adhesions on attempted
refundoplication,33,59,86 or severe gastric paresis.25,81
Intra- and Postoperative Results
The different intra- and postoperative parameters were only
reported in a subset of the original studies. Intraoperative
complications were reported in 454 of 2,123 reoperations
(21.4%) and were more frequent during laparoscopic than
during open abdominal reoperations (150/770, 19.5% vs.
5/92, 5.4%). Laceration or perforation of the esophagus
and/or stomach was the most common (Table 6). Postop-
erative complications were present after 546 of 3,491
reoperations (15.6%). Infectious, pulmonary, and cardiac
complications were the most common postoperative com-
plications (Table 6). Open abdominal reoperations were
accompanied with more complications than laparoscopic
reoperations (55/317, 17.4% vs. 98/642, 15.3%). Thirty-
seven of 4,329 patients (0.9%) died intra- or postoperative-
ly (Table 6). No mortality occurred in studies only reporting
on laparoscopic reoperations, while the mortality rate was
1.3% in studies in which all reoperations were performed
by a conventional abdominal approach.
Mean duration of reoperation was 177.4±10.3 min,
mean intraoperative blood loss 205.5±35.6 ml, and mean
Table 4 Causes of Failure of Previous Antireflux Procedure
n=3,175
Anatomical abnormalities
Intrathoracic wrap migration 885 (27.9%)
Wrap disruption 722 (22.7%)
Telescoping 448 (14.1%)
Para-esophageal hiatal herniation 195 (6.1%)
Hiatal disruption 167 (5.3%)




Esophageal spasms 7 (0.2%)
Sclerodermia 4 (0.1%)
Esophageal carcinoma 1 (0.03%)
Disturbed esophageal motility 13 (0.4%)
No cause for failure identified 194 (6.1%)
Miscellaneous 347 (10.9%)
Not reported 120 (3.8%)
Percentages exceed 100% since more than one cause of failure was
found during several reoperations
Primary procedures (n=4,750) Reoperations (n=4,584)
Indication of operations
Recurrent reflux – 1,912 (41.7%)
Dysphagia – 760 (16.6%)
Recurrent reflux and dysphagia – 184 (4.0%)
Anatomical abnormality – 114 (2.5%)
Gasbloat syndrome – 31 (0.7%)
Miscellaneous – 148 (3.2%)
Not reported – 1,435 (31.3%)
Type of operations
Total fundoplication 2,162 (45.5%) 2,397 (52.3%)
Partial fundoplication 471 (9.9%) 999 (21.8%)
Resection surgery – 327 (7.1%)
Miscellaneous procedures 657 (13.8%) 737 (16.1%)
Not reported 1,460 (30.7%) 124 (2.7%)
Table 3 Type and Indication of
Primary Antireflux Procedures
and Reoperations
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hospital stay 5.5±0.5 days. Comparing results of laparo-
scopic reoperations with laparotomy regarding the preced-
ing parameters was not possible due to the small number of
well-documented studies in the laparotomy group.
Reoperation was performed laparoscopically in 36.3% of
all cases with a conversion rate of 8.7%. Causes of
conversion were dense adhesions (n=57, 39.3%), severe
intraoperative bleeding (n=11, 7.6%), poor visualization
(n=3, 2.1%), and other (n=15, 10.3%). In the remaining 59
cases (40.7%), the reason for conversion was not reported.
Symptomatic Outcome after Reoperations
Symptomatic outcome after reoperation was determined in
79 studies (97.5%)8,10–18,20–28,30–89 and reported as suc-
cessful in 81% of patients, although with different
definitions of success (Table 7). Data were obtained by
questionnaires in 29 studies (36.7%),8,10,11,16–18,20,22–
24,27,28,30,34–37,42,45,46,48,49,54,55,61,69,71,80,84 by interview in
21 (26.6%),13,25,31,38,41,47,52,53,57,60,62,65–68,73,74,78,82,83,85
and this was not reported in the remaining 29 studies
(36.7%).12,14,15,21,26,32,33,39,40,43,44,50,51,56,58,59,63,64,70,72,75–
77,79,81,86–89 The mean success rate in studies only reporting
on laparoscopic reoperations (17 studies)11–13,23–
25,28,31,35,39,41,48,50,53,61,70,85 was 84.2±2.5% and 84.6±
3.4% in studies in which all reoperations were performed
by a conventional abdominal approach (ten stud-
ies).10,22,33,44,58,68,69,75,76,86 In patients in whom the reop-
eration was performed for symptoms only, 82.0±10.7% had
successful symptomatic outcome,47,79 and the success rate
was 81.0±12.1% in patients with recurrent reflux docu-
mented by pH monitoring.10,12,56,89 Comparing the out-
come of total and partial refundoplication, Awad et al.53
reported symptomatic success in 68% and 60% of patients,
respectively. In two other studies,11,45, however, no rela-
tionship between the type of fundoplication and the
symptomatic outcome was found.
Objective Outcome after Reoperations
Objective outcome was reported in 696 patients (15.4%) in
24 studies (29.6%), without a definition of success17,18,20 or
Table 6 Intra- and Postoperative Results of Reoperations
Intraoperative complications N=2,123a





Not reported 6 (0.3%)
Postoperative complications N=3491a
Pulmonary complication 125 (3.6%)
Wound infection 64 (1.8%)
Leakage from alimentary tract 52 (1.5%)
Urinary tract infection 12 (0.3%)
Other infectious complications 48 (1.4%)
Cardiac complications 31 (0.9%)
Hemorrhage 22 (0.6%)
Other 136 (3.9%)
Not reported 56 (1.6%)





Not reported 5 (0.1%)
a Total number of reoperations in which the intra- and postoperative
complications and mortality rate were reported
Table 5 Anatomical Abnormalities Depending on the Approach of Primary Surgery and the Indication of Reoperation
Anatomical abnormalities depending on the approach of primary surgery
Conventional (abdominal) approach (n=120) Laparoscopic approach (n=132)
Wrap disruption 48 (40.0%) 24 (18.2%)
Telescoping 32 (26.6%) 10 (7.6%)
Hiatal disruption 23 (19.2%) 42 (31.8%)
Tight wrap 2 (1.7%) 24 (18.2%)
Miscellaneous 36 (30.0%) 42 (31.8%)
Anatomical abnormalities depending on the indication of reoperation
Recurrent reflux (n=234) Dysphagia (n=118)
Intrathoracic wrap migration 104 (44.4%) 18 (15.3%)
Wrap disruption 109 (46.6%) 12 (10.2%)
No cause of failure 34 (14.5%) 51 (43.2%)
Miscellaneous 64 (27.4%) 54 (45.8%)
Percentages exceed 100% since more than one cause of failure was found during several reoperations
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the number of successful cases,14,17,18,20,28,49,87however, in
seven studies. In the remaining 17 studies, successful
objective outcome was defined as normal acid exposure
during pH monitoring in 11,8,15,19,23,25,36,38,51,57,58,88 ab-
sence of esophagitis in four,10,54,59,76 combination of these
both in one,75 and the absence of reflux during radiologic
imaging in another one.65 In these 17 studies, 78% had a
successful objective outcome (Table 7). The mean success
rate of laparoscopic reoperation (four studies19,23,25,88)
seemed higher than in the case of a conventional abdominal
approach (four other studies10,58,75,76), 85.8±5.6% and
78.0±10.1%, respectively.
Discussion
The often reported observations that morbidity and mortal-
ity are higher after redo antireflux surgery and symptomatic
outcome is inferior to primary antireflux surgery have been
confirmed in this systematic review on all studies currently
available. Very few had a prospective study design, and in
almost half of all, the type of analysis was not even
reported. Moreover, most studies only present symptomatic
outcome, and data on anatomy and function of the
esophagogastric junction are scarce.
Morbidity was most frequently caused by direct injury of
the esophagus and stomach during reoperation in the
current review, and this was confirmed in our own data
on redo surgery,8 mainly as a result of increased complexity
due to adhesions after the primary operation. Most primary
interventions in the studies reviewed were performed by the
conventional approach. Nowadays, with laparoscopy as the
golden standard, less adhesions may be encountered if redo
surgery is required. This might improve the outlook for
these patients with a lower chance of iatrogenic organ
damage, but this has to be proven in future studies.
Although postoperative morbidity and mortality appeared
to be lower after laparoscopic reoperations compared to the
open abdominal approach, intraoperative complications
occurred more frequently during laparoscopic surgery.
These data, however, are not based on comparison between
both approaches within individual studies, and therefore,
this should, in our opinion, be interpreted with caution.
The cause of failure was recognized in 93.8% and
mainly consisted of anatomical abnormalities or an errone-
ous indication for primary surgery. Disruption of hiatal
repair and a too tight wrap were more frequently observed
after the laparoscopic than after the open approach. This
again underlines the difficulty of doing an adequate hiatal
repair and creating a “floppy” wrap by laparoscopy.
Achalasia was the most frequently reported incorrect
diagnosis as the cause of failure, and this supports the
inclusion of esophageal manometry and 24-h pH monitor-
ing in the preoperative workup. It has also been suggested
that a too tight fundoplication can cause an achalasia-like
clinical picture.90 Esophageal manometry shows, in those
circumstances, a non-relaxing lower esophageal sphincter,
but not an aperistaltic esophagus.91
Preoperative workup before reoperation is, apparently,
not standardized but tailored to the cause of failure and the
indication for reoperation. In the case of dysphagia, this
consists of barium swallow to evaluate the esophageal and
gastric anatomy and esophageal manometry to detect
whether or not a motility disorder may be an (additional)
cause of failure. In patients with reflux symptoms,
extensive reevaluation is essential. Symptoms have been
shown, however, to be bad predictors of pathological reflux
after primary antireflux surgery92 and unrelated to anatom-
Table 7 Symptomatic and Objective Outcome after Reoperation
Definition of successful symptomatic outcome in the individual studies Symptomatic outcome Objective outcome
n=79
Degree of symptoms at follow-up 25 (31.6%) –
Patient satisfaction 22 (27.8%) –
Satisfaction defined 6 (27.3%) –
Satisfaction not defined 16 (72.7%) –
Visick grading system 7 (8.9%) –
Visick grading system combined with patient satisfaction 1 (1.3%) –
Scores calculated from specific quality of life questionnaires 5 (6.3%) –
Miscellaneous 5 (6.3%) –
Not reported 14 (17.7%) –
Patients available at follow-up 3 338 (74.0%) 581 (12.9%)
Duration of follow-up (months) 34.2±2.7 21.8±4.7
Patients with successful outcome 2 706 (81.1%) 455 (78.3%)
Values are given as mean±SEM unless otherwise stated
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ical wrap position.93 Therefore, objective preoperative
workup is equal to patients evaluated for primary antireflux
surgery and consists of esophagogastroduodenoscopy,
esophageal manometry, and 24-h pH monitoring, complet-
ed with barium swallow to evaluate the anatomy in addition
to endoscopy.
Symptomatic outcome was described in most studies in
this review with a success rate ranging from 56% to 100%.
The definitions for success showed considerable variation
and focus either on a more general or overall system or on
specific symptoms with or without mentioning data on
quality of life and the effect of surgery on quality of life
aspects, compromising comparison between the individual
studies. Patient satisfaction was a frequently used method
for scoring symptomatic outcome. Patient’s satisfaction is
important and clinically highly relevant, but it does not
directly refer to the specific symptoms of the disease, and
consequently, this type of scoring does not provide insight
in which aspects of the disease have improved and whether
or not reflux symptoms have been exchanged by, for
example, dysphagia. The Visick grading system, indicating
that the disease was cured or improved with Visick grades I
and II or unchanged or worsened in grades III and IV
considered a symptomatic failure,94 correlated well with
postoperative daily reflux related symptoms and daily
complaints of dysphagia in our patient group on redo
antireflux surgery.8
Objective outcome was only reported in less than one
third of the included studies in this review, with a mean
success rate of 78%, which is slightly worse than after
primary surgery. In our unit, all patients are encouraged to
undergo stationary esophageal manometry and ambulatory
24-hr esophageal pH monitoring before and after primary
as well as redo antireflux surgery primarily for quality
control, but also to be able to correlate the functional results
with symptoms and to understand possible future symp-
toms. Although previous studies have shown that for a
good symptomatic outcome after primary surgery optimal
anatomical and functional results are not a prerequisite,92,93
more studies reporting the anatomical and functional status
of the esophagus and stomach after redo surgery are
required to outline a more complete overall picture of the
outcome of redo antireflux surgery.
Conclusion
Redo antireflux surgery has a higher morbidity and
mortality rate than primary antireflux surgery and symp-
tomatic outcome is less satisfactory. Consistency with
regard to reporting on symptomatic and objective outcome
is necessary. Data on objective results after redo antireflux
surgery are scarce and a plea can be made to subject all
primary cases to full-scale evaluation, before and after
antireflux surgery. Data to support this suggestion with
evidence, like adequate cost-effectiveness studies, are
lacking. The relative disappointing results of redo antireflux
surgery with regard to morbidity, mortality, and symptom-
atic outcome support the opinion that redo surgery is
tertiary referral center surgery and these centers should
continue their efforts to collect prospective subjective and
objective data.
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